Dianthus Therapeutics, Inc. (DNTH)

Last Closing Price: 24.81 (2025-08-28)

Earnings per Share (EPS) (Diluted) (Quarterly)

Earnings per Share (EPS) (Diluted): A company's net earnings or losses attributable to common shareholders per diluted share basis, which includes all convertible securities and debt, options and warrants.

Dianthus Therapeutics, Inc. (DNTH) had Earnings per Share (EPS) (Diluted) of $-0.88 for the most recently reported fiscal quarter, ending 2025-06-30.

Figures for fiscal quarter ending 2025-06-30
Income Statement Financials
$0.19M
$-31.63M
--
$0.19M
$35.12M
$-34.93M
$3.30M
$-31.63M
$-31.66M
$-31.63M
$-31.63M
$-31.63M
$-31.66M
$-34.93M
$-35.93M
35.82M
35.82M
$-0.88
Earnings per Share (EPS) (Diluted)
$-0.88
Balance Sheet Financials
$263.61M
$0.21M
$62.47M
$326.08M
$20.09M
--
$2.90M
$23.00M
$303.08M
$303.08M
$303.08M
32.18M
Cash Flow Statement Financials
$-51.52M
$41.24M
$0.73M
$23.02M
$13.47M
$-9.55M
$11.02M
--
--
Fundamental Metrics & Ratios
13.12
--
--
--
--
100.00%
-18096.89%
-18096.89%
--
-16388.08%
-16388.08%
$-51.59M
--
--
--
0.00
--
4.95
18.19
-10.44%
-10.44%
-9.70%
-10.44%
$9.42
$-1.44
$-1.44